AstraZeneca's shares are up 3.5% over the year to date but remain down 11% over the past 52 weeks.

Virginia will continue along its path toward a more independent energy future. And as we do so, it is imperative that we ...

Charles S. Hallab, president and CEO of the US-Saudi Business Council. Listed: $4,690,000. Sold: $4,400,000. Days on market: ...

In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...

Governor Glenn Youngkin spoke with 8News about AstraZeneca’s recent announcement to build their world’s-largest manufacturing ...

The new funding helps Phlow accelerate its mission to help make ingredients for medicines either considered in short supply ...

The company didn’t share specific data for the molecule, gefurulimab, but said it hit all endpoints in the Phase III PREVAIL trial and promised to share more at an upcoming scientific meeting.